389 related articles for article (PubMed ID: 28124939)
1. [Current options of treatment of hyponatremia].
Tesař V
Vnitr Lek; 2016; 62 Suppl 6():97-101. PubMed ID: 28124939
[TBL] [Abstract][Full Text] [Related]
2. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
3. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
[TBL] [Abstract][Full Text] [Related]
4. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
Gargani L; Schmidt PH; Gheorghiade M
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
[TBL] [Abstract][Full Text] [Related]
5. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Nemerovski C; Hutchinson DJ
Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
[TBL] [Abstract][Full Text] [Related]
7. Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.
Pose E; Solà E; Piano S; Gola E; Graupera I; Guevara M; Cárdenas A; Angeli P; Ginès P
Am J Med; 2017 Mar; 130(3):372-375. PubMed ID: 27746291
[TBL] [Abstract][Full Text] [Related]
8. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hyponatremia: role of vaptans].
Hensen J
Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
[TBL] [Abstract][Full Text] [Related]
10. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
Schrier RW; Gross P; Gheorghiade M; Berl T; Verbalis JG; Czerwiec FS; Orlandi C;
N Engl J Med; 2006 Nov; 355(20):2099-112. PubMed ID: 17105757
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
[TBL] [Abstract][Full Text] [Related]
12. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
13. Vaptans for the treatment of hyponatremia.
Robertson GL
Nat Rev Endocrinol; 2011 Mar; 7(3):151-61. PubMed ID: 21283124
[TBL] [Abstract][Full Text] [Related]
14. Electrolytes: Sodium Disorders.
Braun MM; Mahowald M
FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
[TBL] [Abstract][Full Text] [Related]
15. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis.
Meena AK; Nanda PM; Sharma R; Chakrabarty B; Gulati S
Indian J Pediatr; 2024 Feb; 91(2):188-190. PubMed ID: 36757652
[TBL] [Abstract][Full Text] [Related]
17. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
[TBL] [Abstract][Full Text] [Related]
18. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
19. Hypervolemic Hyponatremia (Liver).
Solà E; Ginès P
Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916
[TBL] [Abstract][Full Text] [Related]
20. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Vaghasiya RP; DeVita MV; Michelis MF
Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
